Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Varda Lev-Ram x
  • Refine by access: All content x
Clear All Modify Search
Daniel Nyqvist Department of Molecular Medicine, The Rolf Luft Center for Diabetes Research, Karolinska Institutet, Stockholm, Sweden
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Department of Pharmacology, University of California, San Diego, California, USA
Diabetes Research Institute, The University of Miami School of Medicine, Miami, Florida, USA

Search for other papers by Daniel Nyqvist in
Google Scholar
PubMed
Close
,
Göran Mattsson Department of Molecular Medicine, The Rolf Luft Center for Diabetes Research, Karolinska Institutet, Stockholm, Sweden
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Department of Pharmacology, University of California, San Diego, California, USA
Diabetes Research Institute, The University of Miami School of Medicine, Miami, Florida, USA

Search for other papers by Göran Mattsson in
Google Scholar
PubMed
Close
,
Martin Köhler Department of Molecular Medicine, The Rolf Luft Center for Diabetes Research, Karolinska Institutet, Stockholm, Sweden
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Department of Pharmacology, University of California, San Diego, California, USA
Diabetes Research Institute, The University of Miami School of Medicine, Miami, Florida, USA

Search for other papers by Martin Köhler in
Google Scholar
PubMed
Close
,
Varda Lev-Ram Department of Molecular Medicine, The Rolf Luft Center for Diabetes Research, Karolinska Institutet, Stockholm, Sweden
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Department of Pharmacology, University of California, San Diego, California, USA
Diabetes Research Institute, The University of Miami School of Medicine, Miami, Florida, USA

Search for other papers by Varda Lev-Ram in
Google Scholar
PubMed
Close
,
Arne Andersson Department of Molecular Medicine, The Rolf Luft Center for Diabetes Research, Karolinska Institutet, Stockholm, Sweden
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Department of Pharmacology, University of California, San Diego, California, USA
Diabetes Research Institute, The University of Miami School of Medicine, Miami, Florida, USA

Search for other papers by Arne Andersson in
Google Scholar
PubMed
Close
,
Per-Ola Carlsson Department of Molecular Medicine, The Rolf Luft Center for Diabetes Research, Karolinska Institutet, Stockholm, Sweden
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Department of Pharmacology, University of California, San Diego, California, USA
Diabetes Research Institute, The University of Miami School of Medicine, Miami, Florida, USA

Search for other papers by Per-Ola Carlsson in
Google Scholar
PubMed
Close
,
Astrid Nordin Department of Molecular Medicine, The Rolf Luft Center for Diabetes Research, Karolinska Institutet, Stockholm, Sweden
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Department of Pharmacology, University of California, San Diego, California, USA
Diabetes Research Institute, The University of Miami School of Medicine, Miami, Florida, USA

Search for other papers by Astrid Nordin in
Google Scholar
PubMed
Close
,
Per-Olof Berggren Department of Molecular Medicine, The Rolf Luft Center for Diabetes Research, Karolinska Institutet, Stockholm, Sweden
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Department of Pharmacology, University of California, San Diego, California, USA
Diabetes Research Institute, The University of Miami School of Medicine, Miami, Florida, USA

Search for other papers by Per-Olof Berggren in
Google Scholar
PubMed
Close
, and
Leif Jansson Department of Molecular Medicine, The Rolf Luft Center for Diabetes Research, Karolinska Institutet, Stockholm, Sweden
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Department of Pharmacology, University of California, San Diego, California, USA
Diabetes Research Institute, The University of Miami School of Medicine, Miami, Florida, USA

Search for other papers by Leif Jansson in
Google Scholar
PubMed
Close

Pancreatic islet function and glucose homeostasis have been characterized in the transgenic YC-3.0 mouse, which expresses the yellow chameleon 3.0 (YC-3.0) protein under the control of the β-actin and the cytomegalovirus promoters. Fluorescence from the enhanced yellow fluorescent protein (EYFP), one part of the yellow chameleon protein, was used as a reporter of transgene expression. EYFP was expressed in different quantities throughout most cell types, including islet endocrine and stromal cells. No adverse effects of the transgene on animal health, growth or fertility were observed. Likewise, in vivo glucose homeostasis, mean arterial blood pressure and regional blood flow values were normal. Furthermore, the transgenic YC-3.0 mouse had a normal β-cell volume and mass as well as glucose-stimulated insulin release in vitro, compared with the C57BL/6 control mouse. Isolated islets from YC-3.0 animals continuously expressed the transgene and reversed hyperglycemia when transplanted under the renal capsule of alloxan-diabetic nude mice. We conclude that isolated pancreatic islets from YC-3.0 animals implanted into recipients without any EYFP expression, constitute a novel and versatile model for studies of islet engraftment.

Free access